Research compendium

Macimorelin

Macimorelin is a synthetic peptidomimetic studied as a stimulus in growth-hormone-axis function tests. Adult diagnostic evidence comes from defined designs and comparators. The molecule must be distinguished from a formulated product and from claims about sustained body changes.

This is a research reference, not a product offered in the Asciende catalog. Published studies do not establish the identity, purity or availability of a commercial preparation.

Input signal and axis response

Distinguish local mechanism from integrated effect. A whole-axis result needs its time context and cannot be summarized by a receptor name.

Which level of the endocrine axis was manipulated and which was measured?
Does the readout depend on pulses, time or system feedback?
Are molecular forms or the preparation unambiguously described?

Find readings for this question

Mechanism described in the literature

Official documentation describes growth-hormone secretagogue receptor activity and GH release observed in human studies. The response forms part of a dynamic test; macimorelin is not GH supplied as an ingredient, and these observations do not establish prolonged-exposure effects. Its molecular classification is documented in the official Ghryvelin product information.

Classification

Secretagogue peptidomimetic

Other names

Macimorelin
AEZS-130

An initial comparison remained incomplete

The 2013 multicenter study compared macimorelin with an arginine/GHRH test, but comparator availability changed during the study. Some participants received only the macimorelin test. Not every observation therefore came from a paired comparison, a distinction that must remain in the design summary.

Agreement and diagnostic classification

The 2018 adult crossover trial compared macimorelin with the insulin tolerance test, reporting positive and negative agreement as well as sensitivity and specificity. These are distinct indicators: sharing a classification does not make procedures identical measurements. Later analyses using different cutoffs also do not replace the prespecified analysis.

Population defines the result

In the 2013 study’s adult controls, peak GH was inversely associated with body mass index. That sample-specific association is not a universal individual rule. These studies document diagnostic performance, group composition and discrepancies; they do not turn a one-time test into evidence for other objectives.

Questions and answers

Is macimorelin another GH preparation?

No. It is a peptidomimetic; GH is the hormone whose response was measured.

Does a diagnostic result support sustained effects?

No. The cited designs evaluated dynamic tests and did not establish prolonged-exposure outcomes.